Atropos Health, a pioneer in translating clinical data into personalized real-world evidence (RWE) and insights, announced its selection by Emory Healthcare, an academic health system in Georgia, to generate evidence from real-world data (RWD) through a new decision-making tool for clinicians. The tool aims to improve patient outcomes and lower costs through medication solutions.
“We are already seeing early success as one of our users explored real-world outcomes, adverse events, and costs of a drug that will improve our drug therapy protocol and benefit Emory patients.”
HealthTech Insights: Patients Rely on Reviews, But Few Contribute Their Own, Finds rater8 Study
This collaboration enables Atropos Health to provide rapid evidence generation, advanced analytics, and studies to advance patient care. In the pilot program, Emory is utilizing Atropos Health’s evidence generation platform to answer clinical questions in real-time. By accessing large, historically untapped, local clinical data, Emory and Atropos hope to make impactful changes to medication formulary design and protocols, directly impacting the quality of patient care.
The Atropos EvidenceTM Network, with over 300M patient records, is working with Emory users to run studies on both large national datasets and local Emory data. Clinicians can use the Green ButtonTM for seamless access to real-world evidence, generating results through supervised evidence development or fully automated generative AI version (ChatRWD®) for observation studies delivered in minutes.
HealthTech Insights: DeepScribe & Flatiron Partner for AI in Oncology
“Achieving the quadruple aim in healthcare requires closing the evidence gap,” said Dr. Brigham Hyde, CEO and co-founder of Atropos Health. “Emory’s commitment to adopting technology to reduce friction for physicians and make care protocol and formulary designs based on evidence puts them ahead.”
“Atropos Health provides a means to answer questions not specifically or robustly answered in published data; Atropos surfaces practice-based evidence where evidence-based medicine does not exist,” said Alistair Erskine, MD, Enterprise Chief Information and Digital Officer for Emory Healthcare and Emory University. “We are already seeing early success as one of our users explored real-world outcomes, adverse events, and costs of a drug that will improve our drug therapy protocol and benefit Emory patients.”
HealthTech Insights: Smart Opinion Expands AI Capabilities with Mayo Clinic
Customers rely on Atropos Health’s portfolio of evidence-generating solutions through the federated installation of GENEVA OS™ in their internal cloud data environment. GENEVA OS customers can access Alexandria™, a collection of tens of thousands of existing studies, as well as pre-existing content packages including pharmacy, value-based care, and care management. The existing studies in Alexandria can be rerun on local data to generate novel content and evidence for customer use.
HealthTech Insights: Healthcare Investors Launch ARHI to Set Industry Standards
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – businesswire
